JP2010514421A5 - - Google Patents

Download PDF

Info

Publication number
JP2010514421A5
JP2010514421A5 JP2009543253A JP2009543253A JP2010514421A5 JP 2010514421 A5 JP2010514421 A5 JP 2010514421A5 JP 2009543253 A JP2009543253 A JP 2009543253A JP 2009543253 A JP2009543253 A JP 2009543253A JP 2010514421 A5 JP2010514421 A5 JP 2010514421A5
Authority
JP
Japan
Prior art keywords
vegf
animal
hum
nucleic acid
acid molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009543253A
Other languages
English (en)
Japanese (ja)
Other versions
JP5389665B2 (ja
JP2010514421A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/088537 external-priority patent/WO2008080052A1/en
Publication of JP2010514421A publication Critical patent/JP2010514421A/ja
Publication of JP2010514421A5 publication Critical patent/JP2010514421A5/ja
Application granted granted Critical
Publication of JP5389665B2 publication Critical patent/JP5389665B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009543253A 2006-12-22 2007-12-21 ヒト化ｖｅｇｆを発現するトランスジェニックマウス Expired - Fee Related JP5389665B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87173606P 2006-12-22 2006-12-22
US60/871,736 2006-12-22
PCT/US2007/088537 WO2008080052A1 (en) 2006-12-22 2007-12-21 Transgenic mice expressing humanized vegf

Publications (3)

Publication Number Publication Date
JP2010514421A JP2010514421A (ja) 2010-05-06
JP2010514421A5 true JP2010514421A5 (enExample) 2011-08-18
JP5389665B2 JP5389665B2 (ja) 2014-01-15

Family

ID=39367511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009543253A Expired - Fee Related JP5389665B2 (ja) 2006-12-22 2007-12-21 ヒト化ｖｅｇｆを発現するトランスジェニックマウス

Country Status (5)

Country Link
US (1) US8110720B2 (enExample)
EP (1) EP2099920B1 (enExample)
JP (1) JP5389665B2 (enExample)
ES (1) ES2497496T3 (enExample)
WO (1) WO2008080052A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105950654B (zh) 2010-11-27 2020-03-20 朱坚 一种人源化的转基因动物
JP2016507244A (ja) * 2013-02-27 2016-03-10 ヘルムホルツ・ツェントルム・ミュンヒェン・ドイチェス・フォルシュンクスツェントルム・フューア・ゲズントハイト・ウント・ウムベルト（ゲーエムベーハー）Ｈｅｌｍｈｏｌｔｚ Ｚｅｎｔｒｕｍ ＭｕｅｎｃｈｅｎＤｅｕｔｓｃｈｅｓ Ｆｏｒｓｃｈｕｎｇｓｚｅｎｔｒｕｍ ｆｕｅｒ Ｇｅｓｕｎｄｈｅｉｔ ｕｎｄ Ｕｍｗｅｌｔ （ＧｍｂＨ） Ｃａｓ９ヌクレアーゼによる卵母細胞における遺伝子編集
US20140273031A1 (en) * 2013-03-15 2014-09-18 The Cleveland Clinic Foundation In-vitro method for monoclonal antibody production
BR112016026245A2 (pt) 2014-05-30 2018-02-20 Regeneron Pharma ?roedor, e, métodos para fazer um roedor humanizado, para fazer um camundongo com dpp4 humanizado, para fazer um roedor transgênico humanizado e para determinar a eficácia terapêutica in vivo de um antagonista da dpp4 específica para humanos no roedor?
JP2019506897A (ja) * 2016-01-19 2019-03-14 セルジーン コーポレイション ヒトのセレブロンを発現するトランスジェニックマウス

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US6130071A (en) * 1997-02-05 2000-10-10 Helsinki University Licensing, Ltd. Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof
US6479729B1 (en) * 1998-02-06 2002-11-12 The Johns Hopkins University Mouse model for ocular neovascularization
WO2005042575A2 (en) * 2003-10-30 2005-05-12 Pharmexa A/S Method for down-regulation of vegf

Similar Documents

Publication Publication Date Title
JP2019047818A5 (enExample)
CN105582014B (zh) 用于治疗白血病的组合物和方法
NZ591137A (en) Methods and systems for predicting response of cells to a therapeutic agent
RU2016143376A (ru) ЖИВОТНЫЕ С ГУМАНИЗИРОВАННЫМИ IL-4 И IL-4Rα
JP2010514421A5 (enExample)
JP2014517025A5 (enExample)
SG178567A1 (en) Affinity-matured humanized anti cea monoclonal antibodies
WO2010093872A3 (en) Molecular-based method of cancer diagnosis and prognosis
AU2024203377A1 (en) Altering inflammatory states of immune cells in vivo by modulating cellular activation states
EP3397051B1 (en) Fly avatars for cancer and uses thereof
Chang et al. Effects of bicarbonate stress on serum ions and gill transporters in alkali and freshwater forms of amur ide (Leuciscus waleckii)
JP2010162035A5 (enExample)
EP3664814A1 (en) Rna aptamers against transferrin receptor (tfr)
KR101713407B1 (ko) 아데노바이러스 감염 및 복제가 가능한 흑색종 세포주
Lombardi et al. MET oncogene targeting for cancer immunotherapy
JP2012524248A5 (enExample)
CN102492686B (zh) Kctd10基因剔除小鼠模型、构建方法及其应用
EP2576816A4 (en) METHOD AND KIT FOR THE DISTINCTION BETWEEN BREAST CANCER AND A GOOD BREAST DISEASE
JP5255216B2 (ja) 肺癌モデル動物およびその利用
CN106319043B (zh) 长链非编码rna linc01420的应用方法
ES2940360T3 (es) Polipéptidos capaces de inhibir la unión entre leptina y neuropilina-1
JP2018500882A5 (enExample)
JP2005536535A5 (enExample)
KR101734652B1 (ko) 독소루비신 내성 관련 유전자 및 이의 용도
JP7735260B2 (ja) 老化に影響を及ぼす物質の同定方法